51
Participants
Start Date
August 27, 2021
Primary Completion Date
November 24, 2023
Study Completion Date
November 24, 2023
Ad26.COV2.S
Participants will receive intramuscular (IM) injection of Ad26.COV2.S.
Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto
Shandukani Research Centre, Johannesburg
Medpharmics, LLC, Gulfport
Meridian Clinical Research, LLC, Norfolk
Maximos OB/GYN, League City
Medpharmics, LLC, Albuquerque
Clinical Research College, São Paulo
Universidade Federal De Minas Gerais - Hospital das Clínicas, Belo Horizonte
Sociedade Literaria e Caritativa Santo Agostinho Hospital Sao Jose, Criciúma
Associacaode Ensino de Marilia LTDA - UNIMAR - Universidade de Marilia, Marília
Centro de Estudos e Pesquisas em Moléstias Infecciosas - CEPCLIN, Natal
Hospital das Clinicas de Porto Alegre, Porto Alegre
NPCRS Nucleo de Pesquisa Clinica do Rio Grande do Sul, Porto Alegre
CEMEC - Centro Multidisciplinar de Estudos Clínicos, São Bernardo do Campo
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto Hospital de Base, São José do Rio Preto
CMPC - Consultoria Médica e Pesquisa Clínica, Sorocaba
Ndlovu Elandsdoorn Site, Dennilton
Stanza Clinical Research Centre : Mamelodi, Mamelodi East
Janssen Vaccines & Prevention B.V.
INDUSTRY